We are live on ! Find out more
Fayez Sarofim & Co

Fayez Sarofim & Co Portfolio holdings

AUM $42.5B Turnover 9%
1-Year Est. Return 18.19%
This Fund
S&P 500
This Quarter Est. Return
+11.33%
1 Year Est. Return
+18.19%
3 Year Est. Return
+63.85%
5 Year Est. Return
+89.78%
10 Year Est. Return
+309.54%
AUM
$42.5B
AUM Growth
+$3.46B
Cap. Flow
+$330M
Cap. Flow %
0.78%
Top 10 Hldgs %
48.81%
Holding
311
New
17
Increased
72
Reduced
106
Closed
11
Avg Time Held
7.2 years
Top 10 Avg Time Held
5.5 years
Top 20 Avg Time Held
5.2 years

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$542M
2
MSFT icon
Microsoft
MSFT
+$231M
3
BX icon
Blackstone
BX
+$104M
4
CAT icon
Caterpillar
CAT
+$98M
5
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$90.9M

Top Sells

Rank Stock Value
1
TXN icon
Texas Instruments
TXN
+$150M
2
INTU icon
Intuit
INTU
+$141M
3
ASML icon
ASML
ASML
+$124M
4
ISRG icon
Intuitive Surgical
ISRG
+$120M
5
VRSK icon
Verisk Analytics
VRSK
+$96.9M

Sector Composition

Rank Sector Weight
1 Technology 32.57%
2 Financials 17.95%
3 Consumer Staples 10.49%
4 Communication Services 9.83%
5 Consumer Discretionary 7.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
AAPL icon
1
Apple
AAPL
$5.01T
$4.06B 9.54%
14,030,274
+148,577
+1% +$42.5M
2013 Q2
52 quarters
MSFT icon
2
Microsoft
MSFT
$3.97T
$3.08B 7.25%
8,269,855
+571,842
+7% +$231M
2013 Q2
52 quarters
GOOG icon
3
Alphabet (Google) Class C
GOOG
$4.16T
$2.77B 6.51%
7,841,228
+52,849
+0.7% +$18.9M
2013 Q2
52 quarters
NVDA icon
4
NVIDIA
NVDA
$5.25T
$2.01B 4.72%
10,039,246
+216,420
+2% +$44.5M
2021 Q4
18 quarters
AMZN icon
5
Amazon
AMZN
$2.83T
$1.99B 4.67%
8,342,808
+258,173
+3% +$64.8M
2014 Q2
48 quarters
PM icon
6
Philip Morris
PM
$316B
$1.98B 4.66%
10,966,757
+194,844
+2% +$33.8M
2013 Q2
52 quarters
META icon
7
Meta Platforms (Facebook)
META
$1.79T
$1.25B 2.93%
2,213,318
+74,850
+4% +$45.8M
2014 Q2
48 quarters
KO icon
8
Coca-Cola
KO
$404B
$1.24B 2.92%
15,272,831
+113,599
+0.7% +$8.97M
2013 Q2
52 quarters
TSM icon
9
TSMC
TSM
$2.19T
$1.21B 2.86%
2,543,520
-4,243
-0.2% -$1.72M
2020 Q2
24 quarters
ASML icon
10
ASML
ASML
$640B
$1.17B 2.74%
586,367
-78,102
-12% -$124M
2024 Q1
9 quarters
XOM icon
11
ExxonMobil
XOM
$735B
$1.07B 2.51%
7,817,161
-219,127
-3% -$32.8M
2013 Q2
52 quarters
JPM icon
12
JPMorgan Chase
JPM
$890B
$1.05B 2.47%
3,214,618
+85,496
+3% +$26.6M
2013 Q2
52 quarters
CVX icon
13
Chevron
CVX
$441B
$1.05B 2.46%
6,316,069
+148,302
+2% +$27.6M
2013 Q2
52 quarters
V icon
14
Visa
V
$758B
$1.02B 2.39%
2,969,149
-18,296
-0.6% -$5.87M
2014 Q1
49 quarters
TXN icon
15
Texas Instruments
TXN
$252B
$871M 2.05%
2,921,621
-539,520
-16% -$150M
2013 Q2
52 quarters
MCD icon
16
McDonald's
MCD
$172B
$746M 1.75%
2,760,907
+56,544
+2% +$16.2M
2013 Q2
52 quarters
ABBV icon
17
AbbVie
ABBV
$503B
$724M 1.7%
2,876,785
+120,529
+4% +$25.9M
2013 Q2
52 quarters
UNH icon
18
UnitedHealth
UNH
$364B
$655M 1.54%
1,575,300
-28,472
-2% -$10.6M
2016 Q3
39 quarters
ETN icon
19
Eaton
ETN
$152B
$632M 1.49%
1,483,063
-10,952
-0.7% -$4.42M
2017 Q1
37 quarters
SPGI icon
20
S&P Global
SPGI
$126B
$625M 1.47%
1,533,744
+6,505
+0.4% +$2.75M
2016 Q2
40 quarters
MA icon
21
Mastercard
MA
$540B
$617M 1.45%
1,202,173
-2,484
-0.2% -$1.24M
2013 Q2
52 quarters
BLK icon
22
Blackrock
BLK
$175B
$600M 1.41%
623,951
-12,745
-2% -$13.2M
2013 Q2
52 quarters
EPD icon
23
Enterprise Products Partners
EPD
$79.4B
$588M 1.38%
15,998,982
-200,202
-1% -$7.55M
2013 Q2
52 quarters
AVGO icon
24
Broadcom
AVGO
$1.6T
$535M 1.26%
1,416,634
+1,350,533
+2,043% +$542M
2021 Q1
21 quarters
PGR icon
25
Progressive
PGR
$127B
$524M 1.23%
2,399,296
-65,003
-3% -$13.1M
2017 Q1
37 quarters

Similar funds

Fayez Sarofim & Co's Q2 2026 Portfolio in Review

As of Q2 2026, Fayez Sarofim & Co held 311 positions worth $42.5B, up 8.8% from $39.1B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Fayez Sarofim & Co's Q2 2026 filing shows 17 new, 72 increased, 106 reduced and 11 closed positions. Its largest new stake was AstraZeneca: 179,593 shares worth $34.1M. The largest sale was Texas Instruments, an estimated $150M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Staples.

  • Fayez Sarofim & Co's largest Q2 2026 buy was AstraZeneca: 179,593 shares worth $34.1M.
  • Fayez Sarofim & Co added most to Broadcom in Q2 2026, an estimated $542M increase.
  • Fayez Sarofim & Co's biggest Q2 2026 reduction was Texas Instruments, cutting an estimated $150M.
  • Fayez Sarofim & Co fully exited HDFC Bank in Q2 2026, selling an estimated $8.97M.
  • Fayez Sarofim & Co's ten largest holdings make up 49% of its $42.5B portfolio in Q2 2026.
  • Fayez Sarofim & Co opened 17 new positions and closed 11 in Q2 2026.
  • Fayez Sarofim & Co's portfolio value rose 8.8% quarter-over-quarter to $42.5B.

Based on Fayez Sarofim & Co's 13F filing for Q2 2026, filed 17 Aug 2026.